Skip to main content
. Author manuscript; available in PMC: 2020 Jul 31.
Published in final edited form as: Ann Neurol. 2020 Feb 11;87(4):618–632. doi: 10.1002/ana.25690

Table 3:

Overview of the baseline clinical variables, clinical examination, hospital evaluations and outcomes in a cohort of post-cardiac arrest (n=53) grouped based on presence of BSP on EEG and outcomes within the group of patients with BSP. Data presented as average (IQR) or N/N(%) based on all available data points. (CA: cardiac arrest, OHCA: out-of-hospital cardiac arrest, ROSC: return of spontaneous circulation, TTM: targeted temperature management, SSEP: somatosensory evoked potential, NSE: neuron specific enolase, WLST: withdrawal of life sustaining therapy, CPC: cerebral performance categories).

Total n=53 Patients without BSP (n=36) Patients with BSP
All (n=17) Unfavorable Outcome (n=14) Favorable outcome (n=3)
Baseline characteristics age (at the time of CA) 57.3 (47.25-68) 62.82 (53-78) 65.36 (53-79.5) 51 (45-60.5)
sex, male 24/36 (67%) 13/17 (76%) 10/14 (71%) 3/3 (100%)
setting, OHCA 19/36 (53%) 13/17 (76%) 10/14 (71%) 3/3 (100%)
initial rhythm, shockable^ 13/29 (45%) 7/14 (50%) 4/11 (36%) 3/3 (100%)
Witnessed^ 34/36 (94%) 14/16 (87.5%) 11/13 (85%) 3/3 (100%)
ROSC (minutes)^ 23.8 (9-35) 22.75 (13.75-34.25) 24.64 (15.25-34.75) 9.5 (6.75-12.25)
TTM, target temp 5 (not cooled), 3 (33C), 1 (35.5C), 26 (36C), 1 (n/a) 6 (33C), 1 (34.5C), 9 (36C), 1 (n/a) 5 (33C), 1 (34.5C), 7 (36C), 1 (n/a) 1 (33C), 2 (36C)
length of ICU stay (days) 23.5 (11.75-25.5) 12.7 (7-19) 11.29 (4.75-15.5) 19.3 (18.5-20)
Exam after rewarming/at 72 hours pupillary reflex (present)^ 31/35 (88%) 12/17 (70%) 9/12 (65%) 3/3 (100%)
corneal reflex (present)^ 6/12 (50%) 11/14 (78%) 8/12 (66%) 3/3 (100%)
motor response to pain (better than reflexive) 19/36 (53%) 3/17 (18%) 1/14 (7%) 2/3 (67%)
Prognostic tests SSEP, N20 absent^ 2/13 (15%) 3/8 (38%) 3/7 (43%) 0/1 (0%)
NSE > 33 ug/L^ 6/23 (26%) 7/13 (54%) 7/12 (58%) 0/1 (0%)
MRI, abnormal^ 10/25 (40%) 4/7 (57%) 4/5 (80%) 0/2 (0%)
outcomes Died 18/36 (50%) 13/17 (76%) 13/17 (76%) n/a
Died after WLST 13/18 (72%) 11/13 (85%) 11/13 (85%) n/a
Neurological reason for WLST 10/13 (77%) 9/11 (82%) 9/11 (82%) n/a
Favorable outcome (CPC 1-2) 7/36 (19%) 3/17 (18%) n/a 3/3 (100%)
^

Data not available for all patients.